Dendritic Nanosystems for Biomedical Aplications

The Dendritic Nanosystems for Biomedical Applications research group focuses on the following principal areas:

• Nanosystems as drug carriers for anti‑inflammatory, antiviral and antitumour agents.

• Biomolecule transport, engineering dendritic vehicles for nucleic acids, peptides and proteins.

• Cosmetic antioxidants, developing dendritic nanosystems with free‑radical‑scavenging capacity for skincare.

• Metal–organic complexes, creating dendritic metal complexes with antiviral, antibacterial and anticancer activity.

• Antimicrobial and antiparasitic agents, designing dendritic antivirals (notably HIV inhibitors), antibacterials and antiparasitics.

• Agrobiotechnology, applying dendritic nanostructures to crop protection and enhancement.

• Vaccine platforms, exploring dendritic systems for antigen delivery and immunomodulation.

• Synthetic innovation, devising novel strategies to synthesise and functionalise dendrimers.

• Neurodegenerative disease, tailoring dendritic nanosystems for diagnosis and therapy of disorders such as Alzheimer’s and Parkinson’s.

• Bactericidal surfaces, generating coatings and materials that actively kill or inhibit bacterial growth.

The group provides contract research services in:

• Synthesising multifunctional dendrimers of diverse topologies

• Synthesising and fully characterising organic and inorganic compounds

• Advanced nano‑chemistry techniques

Current projects:

• Development of a depigmenting and antioxidant cosmetic formulation based on metal nanoparticles functionalised with caffeic acid.

• Design of a multicomponent nanoscale approach for responsive, transungual treatment of rheumatoid arthritis.

More information:Biomedicas Dendritic Nanosystems for Biomedical Aplications